Financing, Equity Capital Markets
BioCryst Pharmaceuticals, Inc.
05/20
|
$100.0 Million
![](/sites/default/files/images/custom/biocryst-pharmaceuticals-inc.png)
Piper Sandler served as bookrunner for BioCryst Pharmaceuticals, Inc. on a confidentially marketed follow-on offering